Atrial Fibrillation
People with amyloidosis have a significantly higher prevalence of atrial fibrillation.
In approximately 50% of patients, pulmonary vein isolation (PVI) successfully treats persistent AFib at one year.
Théophile Mohr-Durdez, CEO and co-founder of Volta Medical, talks about streamlining workflows for electrophysiologists.
People who quit smoking have a lower risk of atrial fibrillation than people who continue to smoke.
The EPIC-CAD trial addresses a crucial question in managing patients with both atrial fibrillation and stable CAD.
PVI results in clinically important improvements in both symptom burden and quality of life compared with a placebo.
Patients with inflammatory bowel disease have a significantly higher risk of developing atrial fibrillation.
Monitoring heart rate and physical activity using a wearable device has clinical value.
Both rare and common genetic variation is associated with an increased risk of atrial fibrillation.
A recent study found that 73% of patients with ATTR-CA had AF at diagnosis.
Advertisement
Expert Interviews on Atrial Fibrillation
Dr. Hady Lichaa explains a pseudoaneurysm thrombin injection technique.
Dr. Kohli discusses the SELECT trial, which showed that semaglutide can benefit obese patients with heart disease.
Dr. Erin Michos joins The CardioNerds to discuss the Women’s Cardiometabolic Health and Wellness Masterclass.
February is American Heart Month— a fitting time to highlight the interesting correlation between heart disease and ...
Holographic Therapy Guidance (HTG) is a new technology developed by EchoPixel that generates a real-time digital ...
Eating healthy can be a challenge for many people; however, a balanced and nutritious diet is crucial for cardiovascular ...
Advertisement
DocWire News provides the latest clinical updates, conference coverage, and more, highlighting advancements across all medical specialties.
Get research and breaking news straight to your inbox.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.